Concepts (77)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Resistance, Viral | 5 | 2024 | 67 | 0.730 |
Why?
|
| HIV-1 | 6 | 2024 | 755 | 0.720 |
Why?
|
| Evolution, Molecular | 3 | 2006 | 307 | 0.450 |
Why?
|
| HIV Infections | 6 | 2024 | 2586 | 0.400 |
Why?
|
| HIV Integrase Inhibitors | 2 | 2024 | 11 | 0.390 |
Why?
|
| Mutation | 5 | 2021 | 1177 | 0.380 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 3 | 2006 | 57 | 0.350 |
Why?
|
| Simian immunodeficiency virus | 3 | 2006 | 60 | 0.350 |
Why?
|
| Vagina | 3 | 2005 | 89 | 0.320 |
Why?
|
| Anti-HIV Agents | 2 | 2004 | 486 | 0.310 |
Why?
|
| Pyridones | 2 | 2024 | 50 | 0.250 |
Why?
|
| Morphine Dependence | 1 | 2006 | 23 | 0.240 |
Why?
|
| HIV Integrase | 1 | 2024 | 22 | 0.220 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2005 | 247 | 0.200 |
Why?
|
| Genes, pol | 3 | 2005 | 15 | 0.170 |
Why?
|
| HIV Protease | 3 | 2005 | 23 | 0.160 |
Why?
|
| HIV Reverse Transcriptase | 3 | 2005 | 35 | 0.160 |
Why?
|
| Amino Acid Sequence | 4 | 2006 | 1180 | 0.150 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2005 | 229 | 0.150 |
Why?
|
| Molecular Sequence Data | 4 | 2006 | 1542 | 0.150 |
Why?
|
| RNA, Viral | 5 | 2006 | 321 | 0.130 |
Why?
|
| Morphine | 2 | 2006 | 69 | 0.120 |
Why?
|
| Virus Replication | 2 | 2006 | 318 | 0.100 |
Why?
|
| Phylogeny | 2 | 2006 | 769 | 0.090 |
Why?
|
| Macaca mulatta | 3 | 2006 | 139 | 0.090 |
Why?
|
| Viral Load | 4 | 2006 | 348 | 0.090 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2006 | 201 | 0.070 |
Why?
|
| Telencephalon | 1 | 2006 | 13 | 0.060 |
Why?
|
| Retroviruses, Simian | 1 | 2005 | 3 | 0.060 |
Why?
|
| Adult | 5 | 2005 | 13872 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2004 | 515 | 0.060 |
Why?
|
| Diketopiperazines | 1 | 2024 | 5 | 0.050 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2024 | 10 | 0.050 |
Why?
|
| Gene Products, tat | 1 | 2004 | 36 | 0.050 |
Why?
|
| Quinolones | 1 | 2024 | 14 | 0.050 |
Why?
|
| Oxazines | 1 | 2024 | 32 | 0.050 |
Why?
|
| Candidiasis, Oral | 1 | 2004 | 24 | 0.050 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2004 | 44 | 0.050 |
Why?
|
| Genes, Viral | 1 | 2004 | 61 | 0.050 |
Why?
|
| Disease Transmission, Infectious | 1 | 2004 | 30 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2006 | 226 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 135 | 0.050 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2004 | 74 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2004 | 272 | 0.050 |
Why?
|
| Piperazines | 1 | 2024 | 120 | 0.050 |
Why?
|
| Epitopes | 1 | 2004 | 157 | 0.050 |
Why?
|
| Humans | 7 | 2024 | 43102 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2024 | 201 | 0.050 |
Why?
|
| Disease Progression | 1 | 2006 | 667 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 652 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2004 | 311 | 0.050 |
Why?
|
| Alcoholism | 1 | 2005 | 305 | 0.040 |
Why?
|
| Phenotype | 1 | 2024 | 780 | 0.040 |
Why?
|
| Female | 4 | 2005 | 24698 | 0.040 |
Why?
|
| Puerto Rico | 2 | 2021 | 1413 | 0.040 |
Why?
|
| Receptors, CCR5 | 1 | 1998 | 64 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1998 | 93 | 0.030 |
Why?
|
| HIV Seropositivity | 1 | 1998 | 196 | 0.030 |
Why?
|
| CD4-CD8 Ratio | 2 | 2006 | 29 | 0.030 |
Why?
|
| Animals | 3 | 2006 | 16992 | 0.030 |
Why?
|
| Middle Aged | 2 | 2005 | 12222 | 0.020 |
Why?
|
| Time Factors | 2 | 2005 | 1857 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 1 | 2006 | 20 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2006 | 74 | 0.020 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2004 | 55 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2005 | 184 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2006 | 306 | 0.010 |
Why?
|
| Male | 4 | 2006 | 23409 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2005 | 279 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 1596 | 0.010 |
Why?
|
| Heterozygote | 1 | 1998 | 110 | 0.010 |
Why?
|
| Genotype | 1 | 1998 | 800 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1998 | 972 | 0.010 |
Why?
|
| Infant | 1 | 1998 | 1175 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1998 | 1546 | 0.010 |
Why?
|
| Child | 1 | 1998 | 3443 | 0.000 |
Why?
|
| Adolescent | 1 | 1998 | 6081 | 0.000 |
Why?
|